AstraZeneca Resumes Its COVID-19 Vaccine Trials In The U.K.

Content Curator
Earlier in the week AstraZeneca had paused worldwide studies of its candidate vaccine after one U.K. participant developed symptoms consistent with the spinal cord inflammation known as transverse myelitis.

The company had placed its worldwide vaccine trials on hold for several days, but now says a safety review by regulators and reviewers is complete. No word yet when studies in the U.S. might resume.

(Image credit: Alastair Grant/AP)